Abbott stock sinks 7% after revenue miss, softer Q1 view puts nutrition back in focus
New York, Jan 22, 2026, 10:14 EST — Regular session Abbott Laboratories shares dropped 7.4%, hitting $111.74 in morning trading after falling as low as $106.13. The slide came on the back of a quarterly revenue miss and a cautious outlook on near-term profits.